Hypoglycaemia in elderly diabetic patients

Diabetes and Metabolism

Volumn 31, Issue SPEC. ISS. 2, 2005, Pages

  Lassmann Vague, V ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Antidiabetic treatment; Diabetes mellitus; Elderly patients; Hypoglycaemia

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; INSULIN; INSULIN DERIVATIVE; METFORMIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; REPAGLINIDE; SULFONYLUREA; TOLBUTAMIDE;

BLOOD GLUCOSE MONITORING; CAREGIVER; CLINICAL FEATURE; COMORBIDITY; CONTROLLED RELEASE FORMULATION; DIABETES MELLITUS; DIABETIC DIET; DISEASE PREDISPOSITION; DRUG EXCRETION; DRUG METABOLISM; DRUG SAFETY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY FAILURE; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PREVENTIVE HEALTH SERVICE; PROGNOSIS; REVIEW; RISK ASSESSMENT;

EID: 30844471174     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1262-3636(05)73651-x     Document Type: Review

References (32)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
3. Murata GH, Duckworth WC, Shah JH, Wendel CS, Mohler MJ, Hoffman RM. Hypoglycaemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1,662 episodes. J Diabetes Complications 2005;19:10-7.
4. Jaap AJ, Jones GC, McCrimmon RJ, Deary IJ, Frier BM. Perceived symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin. Diabet Med 1998;15:398-401.
5. Stepka M, Rogola H, Czyzyk A. Hypoglycaemia: a major problem in the management of diabetes in the elderly. Aging (Milano) 1993;5:117-21.
6. Holstein A, Plaschke A, Egberts EH. Clinical characterisation of severe hypoglycaemia: a prospective population-based study. Exp Clin Endocrinol Diabetes 2003;111:364-9.
7. Teo SK, Ee CH. Hypoglycaemia in the elderly. Singapore Med J 1997;38:432-4.
8. Trovati M, Burzacca S, Mularoni E, et al. Occurrence of low blood glucose concentrations during the afternoon in type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring. Diabetologia 1991;34:662-7.
9. Seltzer HS. Drug-induced hypoglycaemia. A review based on 473 cases. Diabetes 1972;21:955-66.
10. Chan TY. Estimates on the incidence of antidiabetic drug-induced severe hypoglycaemia in Hong Kong. Pharmacoepidemiol Drug Saf 1998;7:411-4.
11. Shorr RI, Ray WA, Daugherty JR, et al. Incidence and risk factors for serious hypoglycaemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997;157:1681-6.
12. Murata GH, Hoffman RM, Shah JH, Wendel CS, Duckworth WC. A probabilistic model for predicting hypoglycaemia in type 2 diabetes mellitus: The Diabetes Outcomes in Veterans Study (DOVES). Arch Intern Med 2004;164:1445-50.
13. Hay LC, Wilmshurst EG, Fulcher G. Unrecognized hypo- and hyperglycaemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diabetes Technol Ther 2003;5:19-29.
14. Meneilly GS, Cheung E, Tuokko H. Counterregulatory hormone responses to hypoglycaemia in the elderly patient with diabetes. Diabetes 1994;43:403-10.
15. Matyka K, Evans M, Lomas J, Cranston I, McDonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycaemia in normal aging in healthy men. Diabetes Care 1997;20:135-41.
16. Pham M, Pinganaud G, Richard-Harston S, Decamps A, Bourdel-Marchasson I. Prospective audit of diabetes care and outcomes in a group of geriatric French care homes. Diabetes Metab 2003;29:251-8.
17. Corsonello A, Pedone C, Corica F, et al. Antihypertensive drug therapy and hypoglycaemia in elderly diabetic patients treated with insulin and/or sulfonylureas. Gruppo Italiano di Farmacovigilanza nell'Anziano (GIFA). Eur J Epidemiol 1999;15:893-901.
18. Wright A, Burden ACF, Paisey RB, Cull CA, Holman RR; UK Prospective Diabetes Study Group. Sulfonylurea indadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002;25:330-6.
19. Yki-Järvinen H, Ryysy L, Nikkilä K, Tulokas T, Vanamo R, Heikkilä M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1999;130:389-96.
20. Wolffenbuttel BHR, Sels JP, Rondas-Colbers GJ, Menheere PP, Nieuwenhuijzen-Kruseman AC. Comparison of different insulin regimens in elderly patients with NIDDM. Diabetes Care 1996;19:1326-32.
21. Abraira C, Colwell JA, Nuttall FQ, et al., VM CSDM Group. Veterans Affairs Cooperative Study on glycaemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Diabetes Care 1995;18:1113-23.
22. Porcellati F, Rossetti P, Pampanelli S, et al. Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with type 1 diabetes mellitus given meal-time lispro insulin. Diabet Med 2004;21:1213-20.
23. Warren ML, Conway MJ, Klaff LJ, Rosenstock J, Allen E. Postprandial versus preprandial dosing of biphasic insulin aspart in elderly type 2 diabetes patients. Diabetes Res Clin Pract 2004;66:23-9.
24. Tessier D, Dawson K, Tétrault JP, Bravo G, Meneilly GS. Glibenclamide vs gliclazide in type 2 diabetes of the elderly. Diabet Med 1994;11:974-80.
25. Schernthaner G, Grimaldi A, Di Mario U, et al. GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest 2004;34:535-42.
26. Balfour JA, Faulds D. Repaglinide. Drugs Aging 1998;13:173-80.
27. Erratum in: Drugs Aging 1999;15:28.
28. Rajagopalan R, Perez A, Ye Z, Khan M, Murray FT. Pioglitazone is effective therapy for elderly patients with type 2 diabetes mellitus. Drugs Aging 2004;21:259-71.
29. Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med 2003;20:1016-21.
30. Segel SA, Paramore DS, Cryer PE. Hypoglycaemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 2002;51:724-33.
31. Burge MR, Sobhy TA, Qualls CR, Schade DS. Effect of short-term glucose control on glycaemic thresholds for epinephrine and hypoglycaemic symptoms. J Clin Endocrinol Metab 2001;86:5471-8.
32. Huang ES, Gorawara-Bhat R, Chin MH. Self-reported goals of older patients with type 2 diabetes mellitus. J Am Geriatr Soc 2005;53:306-11.